Timothy John Floreth, MD | |
2 Tampa General Cir, Tampa, FL 33606-3603 | |
(813) 974-2201 | |
Not Available |
Full Name | Timothy John Floreth |
---|---|
Gender | Male |
Speciality | Internal Medicine - Pulmonary Disease |
Location | 2 Tampa General Cir, Tampa, Florida |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205852381 | NPI | - | NPPES |
003606400 | Medicaid | FL | |
14CWS | Other | FL | BLUE CROSS BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | ME143506 (Florida) | Secondary |
207RP1001X | Internal Medicine - Pulmonary Disease | ME143506 (Florida) | Primary |
Entity Name | Regents Of The University Of California |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376646869 PECOS PAC ID: 3577476761 Enrollment ID: O20031112000695 |
News Archive
The research team asked a representative sample of 764 men to weigh and record every item of food and drink they consumed for seven consecutive days. Just under 90% of the sample (665) produced complete and detailed diaries.
Tuberculosis is distinguished primarily by the persistent cough that serves to spread the disease. Stopping whatever triggers that cough could greatly reduce the transmission of the disease, which annually kills more than 1.3 million people worldwide.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
NextBio, developer of an innovative software platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, today announced a license agreement with global biopharmaceutical company UCB, for NextBio Enterprise. NextBio Enterprise offers life sciences organizations unique tools for knowledge discovery and collaboration, seamless integration of internal and external research data, and secure data access.
› Verified 4 days ago
Entity Name | Regents Of The University Of California |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386762300 PECOS PAC ID: 3577476761 Enrollment ID: O20040430001307 |
News Archive
The research team asked a representative sample of 764 men to weigh and record every item of food and drink they consumed for seven consecutive days. Just under 90% of the sample (665) produced complete and detailed diaries.
Tuberculosis is distinguished primarily by the persistent cough that serves to spread the disease. Stopping whatever triggers that cough could greatly reduce the transmission of the disease, which annually kills more than 1.3 million people worldwide.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
NextBio, developer of an innovative software platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, today announced a license agreement with global biopharmaceutical company UCB, for NextBio Enterprise. NextBio Enterprise offers life sciences organizations unique tools for knowledge discovery and collaboration, seamless integration of internal and external research data, and secure data access.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Timothy John Floreth, MD Po Box 917770, Orlando, FL 32891-0001 Ph: () - | Timothy John Floreth, MD 2 Tampa General Cir, Tampa, FL 33606-3603 Ph: (813) 974-2201 |
News Archive
The research team asked a representative sample of 764 men to weigh and record every item of food and drink they consumed for seven consecutive days. Just under 90% of the sample (665) produced complete and detailed diaries.
Tuberculosis is distinguished primarily by the persistent cough that serves to spread the disease. Stopping whatever triggers that cough could greatly reduce the transmission of the disease, which annually kills more than 1.3 million people worldwide.
Genzyme, a Sanofi company, announced today that Brazil's national health surveillance agency, ANVISA, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
NextBio, developer of an innovative software platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, today announced a license agreement with global biopharmaceutical company UCB, for NextBio Enterprise. NextBio Enterprise offers life sciences organizations unique tools for knowledge discovery and collaboration, seamless integration of internal and external research data, and secure data access.
› Verified 4 days ago
Chhavi Gupta, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 508 S Habana Ave., Suite 270, Tampa, FL 33609 Phone: 813-388-1732 Fax: 813-864-9292 | |
Dr. Luis Leon Alvarado, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 13000 Bruce B Downs Blvd, Va 111, Tampa, FL 33612 Phone: 813-972-2000 Fax: 813-631-3423 | |
Dr. Nirmal Shyam Sharma, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2 Tampa General Cir Fl Circle6, Tampa, FL 33606 Phone: 813-974-2201 | |
Aniqa Shahrier, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3003 W Dr Martin Luther King Jr Blvd Fl 3, Tampa, FL 33607 Phone: 877-537-4787 | |
Sriprintha Navarathinarajah, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5130 Sunforest Dr Ste 300, Tampa, FL 33634 Phone: 727-824-0780 Fax: 813-514-8891 | |
Dr. Olga Kaliebe, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2919 W Swann Ave, Tampa, FL 33609 Phone: 813-392-1900 Fax: 813-392-1901 | |
William Dinwoodie, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 12902 Usf Magnolia Dr, Mdc 44, Tampa, FL 33612 Phone: 813-745-3980 Fax: 813-745-7229 |